Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
| Molecular Weight | 370.09 g/mol |
|---|---|
| Molecular Formula | C10H18FeO11 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 0 |
| Exact Mass | 370.019847 g/mol |
| Monoisotopic Mass | 370.019847 g/mol |
| Topological Polar Surface Area | 191 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 323 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
ABOUT THIS PAGE
A Iron Hydroxide Adipate Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iron Hydroxide Adipate Tartrate, including repackagers and relabelers. The FDA regulates Iron Hydroxide Adipate Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iron Hydroxide Adipate Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iron Hydroxide Adipate Tartrate supplier is an individual or a company that provides Iron Hydroxide Adipate Tartrate active pharmaceutical ingredient (API) or Iron Hydroxide Adipate Tartrate finished formulations upon request. The Iron Hydroxide Adipate Tartrate suppliers may include Iron Hydroxide Adipate Tartrate API manufacturers, exporters, distributors and traders.
Iron Hydroxide Adipate Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iron Hydroxide Adipate Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iron Hydroxide Adipate Tartrate GMP manufacturer or Iron Hydroxide Adipate Tartrate GMP API supplier for your needs.
A Iron Hydroxide Adipate Tartrate CoA (Certificate of Analysis) is a formal document that attests to Iron Hydroxide Adipate Tartrate's compliance with Iron Hydroxide Adipate Tartrate specifications and serves as a tool for batch-level quality control.
Iron Hydroxide Adipate Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Iron Hydroxide Adipate Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iron Hydroxide Adipate Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Iron Hydroxide Adipate Tartrate EP), Iron Hydroxide Adipate Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iron Hydroxide Adipate Tartrate USP).
LOOKING FOR A SUPPLIER?
